Abstract
The pharmacokinetics of ofloxacin were studied in 12 intensive care patients, 6 of whom were under controlled mechanical ventilation. All patients had a creatinine clearance of greater than 80 ml/min per 1.73 m2. They were given 3 mg of ofloxacin per kg of body weight intravenously at a constant flow rate in 30 min twice a day for 7 days. Pharmacokinetic studies were performed on days 1 and 7. Between days 1 and 7, significant increases in the alpha (distribution) and beta (elimination) phase half-lives, the area under the serum concentration-time curve, and peak and trough levels in serum were observed, together with a marked decrease (greater than 50%) in total body clearance. Possible contributing factors for alteration of ofloxacin pharmacokinetics in ventilated patients were patient age, liver dysfunction, drug interaction, and drug accumulation in a deep compartment. This study shows that in intensive care patients the pharmacokinetics of ofloxacin differ from those reported for healthy volunteers.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aronoff G. E., Kenner C. H., Sloan R. S., Pottratz S. T. Multiple-dose ciprofloxacin kinetics in normal subjects. Clin Pharmacol Ther. 1984 Sep;36(3):384–388. doi: 10.1038/clpt.1984.192. [DOI] [PubMed] [Google Scholar]
- Dagrosa E. E., Verho M., Malerczyk V., de Looze S., Hajdú P., Toyodera K. Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent. Clin Ther. 1986;8(6):632–645. [PubMed] [Google Scholar]
- De Bernardis E., Bonaccorsi S., Carlino S., Picari M., Rizza V. Pharmacokinetics and tissue distribution of ofloxacin in human subjects during a multiple dose regimen. Int J Clin Pharmacol Res. 1988;8(4):239–245. [PubMed] [Google Scholar]
- Farinotti R., Trouvin J. H., Bocquet V., Vermerie N., Carbon C. Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects. Antimicrob Agents Chemother. 1988 Oct;32(10):1590–1592. doi: 10.1128/aac.32.10.1590. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fillastre J. P., Leroy A., Humbert G. Ofloxacin pharmacokinetics in renal failure. Antimicrob Agents Chemother. 1987 Feb;31(2):156–160. doi: 10.1128/aac.31.2.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Frydman A. M., Le Roux Y., Lefebvre M. A., Djebbar F., Fourtillan J. B., Gaillot J. Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers. J Antimicrob Chemother. 1986 Apr;17 (Suppl B):65–79. doi: 10.1093/jac/17.suppl_b.65. [DOI] [PubMed] [Google Scholar]
- Martin C., Alaya M., Bras J., Saux P., Gouin F. Assessment of creatinine clearance in intensive care patients. Crit Care Med. 1990 Nov;18(11):1224–1226. doi: 10.1097/00003246-199011000-00007. [DOI] [PubMed] [Google Scholar]
- Martin C., Mallet M. N., Saux P., Bruguerolle B., Herat V., Gouin F. Tobramycin dosing in mechanically ventilated patients. Inaccuracy of a 'rule of thumb'. J Antimicrob Chemother. 1988 Oct;22(4):505–511. doi: 10.1093/jac/22.4.505. [DOI] [PubMed] [Google Scholar]
- Mignot A., Lefebvre M. A., Fourtillan J. B. High-performance liquid chromatographic determination of ofloxacin in plasma and urine. J Chromatogr. 1988 Aug 19;430(1):192–197. doi: 10.1016/s0378-4347(00)83152-7. [DOI] [PubMed] [Google Scholar]
- Neuman M. Comparative pharmacokinetic parameters of new systemic fluoroquinolones. Int J Clin Pharmacol Res. 1987;7(3):173–179. [PubMed] [Google Scholar]
- Veyssier P., Fourtillan J. B., Modai J., Couet W., Lefebvre M. A., Darchis J. P., Vincent Du Laurier M., Bryskier A. Pharmacocinétique de l'ofloxacine chez le sujet âge (65 à 85 ans) à fonction rénale normale après prise orale unique de 200 mg. Pathol Biol (Paris) 1986 Jun;34(5 Pt 2):596–599. [PubMed] [Google Scholar]